Altogether, we have identified an unexpected activity of TFEB-mediated autophagy–lysosomal function in regulating TGF-β signaling, which when compromised, promotes tumor progression and drug resistance in BRAF-mutant melanoma. The gene discussed is TFEB; the disease is neoplasm.